Reply to: Comments on "Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial".
Simone N Koole
,
Philip C Schouten
,
Willemien J van Driel
,
Gabe S Sonke
,
Sabine C Linn
More about this publication
International journal of cancer
Volume
151
Issue nr.
11
Pages
2057-2058
Publication date
01-12-2022
Full text links
Publisher website (DOI)
10.1002/ijc.34219
Europe PubMed Central
35857410
Pubmed
35857410